trial · primary record
ONC201
Endometrial Cancer
| Phase | Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 19 |
| Primary completion | 2020-09-09 |
| Primary endpoint | Progression Free Survival (PFS) Rate at 12 Weeks |
| Registry ID | NCT03099499 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:58:48.465Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03099499
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.